Dr. Buccafusco co-edits book on animal models for cognitive disorders
[Press Release] Medical College of Georgia - Jun 20 7:06 AM
Dr. Jerry J. Buccafusco, founding director of the Alzheimers Research Center at the Medical College of Georgia, is co-editor of a new textbook, Animal Models of Cognitive Impairment.Save to My Web
Eating ‘Smart’: 9 Super Foods for Better Brain
Fox News - Jun 21 3:58 PM
Add these nine superfoods to your daily diet, and you will increase your odds of maintaining a healthy brain for the rest of your life.Save to My Web
Alzheimer’s Disease: ; Daughter Recalls Struggle to Maintain Care for Her Father
RedNova - Jun 19 9:15 PM
By Kathryn E. Brown “Your father is homeless.” There are certain announcements in our lives, both good and bad, that simply leave us speechless. I want you to be my wife. It’s a boy! You’re hired. You’re fired. Not guilty.Save to My Web
Tiny transmitters track wanderers
The Cincinnati Enquirer - 1 hour, 32 minutes ago
A downsized version of a device used to track animals in the wild will be used to help find people with Alzheimer’s disease and other mental conditions who wander off in Butler County.Save to My Web
KIM ADAMS | KIM’S GOOD HEALTH: Help for Alzheimer’s
Detroit Free Press - Jun 20 1:56 AM
An experimental vaccine against Alzheimer’s disease is showing signs of reducing brain deposits that are blamed for the disorder, according to the Associated Press. Tests in mice have shown up to a 38.5% decrease in the deposits with no major side effects. The DNA-based vaccine is now being tested in monkeys. If successful, human testing may begin within the next three years.Save to My Web
WALLACE Y. ELDRIDGE
Northwest Herald - Jun 22 12:33 AM
Born: Aug. 15, 1927; in Portsmith, N.H. MARENGO Wallace Y. Eldridge, 78, of Marengo, died Thursday, June 15, 2006, at Provena St. Joseph Hospital in Elgin.Save to My Web
First Ever Disease-Modifying Drugs Will Account for Nearly 60% of Market to Treat Alzheimer’s Disease In 2015
[Press Release] PR Newswire via Yahoo! Finance - Jun 19 5:00 AM
Decision Resources, Inc., one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that Neurochem’s Alzhemed and Myriad Genetics’ Flurizan will account for nearly 60% of the market to treat Alzheimer’s disease in 2015.Save to My Web
South Korea to begin trial of disgraced cloning scientist Hwang
The Star Online - Jun 21 7:53 PM
SEOUL, South Korea (AP) - South Korea was set to put disgraced cloning scientist Hwang Woo-suk on trial Tuesday on charges of fraud and embezzlement over his faked stem cell research.Save to My Web